SIC 2835 – In Vitro and In Vivo Diagnostic Substances
Valuation | |
---|---|
Market Cap ($M) | 2,018.25 |
Enterprise Value ($M) | 4,588.85 |
Book Value ($M) | 2,997.20 |
Book Value / Share | 44.40 |
Price / Book | 0.67 |
NCAV ($M) | -2,206.20 |
NCAV / Share | -32.68 |
Price / NCAV | -0.91 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.06 |
Return on Assets (ROA) | -0.05 |
Return on Equity (ROE) | -0.11 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.66 |
Current Ratio | 1.20 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 1,258.20 |
Assets | 6,461.60 |
Liabilities | 3,464.40 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 2,782.90 |
Operating Income | 45.80 |
Net Income | -2,027.00 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 83.00 |
Cash from Investing | -149.90 |
Cash from Financing | 48.80 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | T. Rowe Price Investment Management, Inc. | 16.70 | 19.59 | |
13G/A | Rubric Capital Management LP | 8.25 | 32.14 | |
13G | Invesco Ltd. | 5.10 | ||
13G/A | BlackRock, Inc. | 12.50 | 16.04 | |
13G/A | Vanguard Group Inc | 10.13 | 12.67 | |
13D/A | Carlyle Group Inc. | 0.00 | -100.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
425,550 | 981,726 | 43.35 | |
286,093 | 942,780 | 30.35 | |
143,897 | 602,944 | 23.87 | |
170,538 | 723,154 | 23.58 | |
(click for more detail) |
Similar Companies | |
---|---|
PRTA – Prothena Corporation plc | PTCT – PTC Therapeutics, Inc. |
PYXS – Pyxis Oncology, Inc. | QNCX – Quince Therapeutics, Inc. |
QURE – uniQure N.V. |
Financial data and stock pages provided by
Fintel.io